J Stroke.  2025 Jan;27(1):122-127. 10.5853/jos.2024.03944.

Parkinsonism in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Clinical Features and Biomarkers

• Chen CH
• Wang TW
• Cheng YW
• Chu YT
• Cheng MF
• Chen YF
• Lin CH
• Tang SC

• KMID: 2564270
• DOI: http://doi.org/10.5853/jos.2024.03944

Figure

• 

  Figure 1. Clinical features and biomarkers of parkinsonism in CADASIL patients. (A) Exemplar brain MRI results in CADASIL patients with parkinsonism at different H-Y stages. Comparisons between CADASIL patients with parkinsonism (CAD) and idiopathic Parkinson’s disease patients (IPD). (B) UPDRS-III category score. (C) Alpha-synuclein level at different H-Y stages. MRI, magnetic resonance imaging; CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; H-Y, Hoehn-Yahr; UPDRS-III, Unified Parkinson’s Disease Rating Scale part III.

Reference

References

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010; 9:689–701.

2. van der Holst HM, van Uden IW, Tuladhar AM, de Laat KF, van Norden AG, Norris DG, et al. Cerebral small vessel disease and incident parkinsonism: the RUN DMC study. Neurology. 2015; 85:1569–1577.

3. Rektor I, Bohnen NI, Korczyn AD, Gryb V, Kumar H, Kramberger MG, et al. An updated diagnostic approach to subtype definition of vascular parkinsonism–recommendations from an expert working group. Parkinsonism Relat Disord. 2018; 49:9–16.

4. Ragno M, Berbellini A, Cacchiò G, Manca A, Di Marzio F, Pianese L, et al. Parkinsonism is a late, not rare, feature of CADASIL: a study on Italian patients carrying the R1006C mutation. Stroke. 2013; 44:1147–1149.

5. Min JY, Park SJ, Kang EJ, Hwang SY, Han SH. Mutation spectrum and genotype-phenotype correlations in 157 Korean CADASIL patients: a multicenter study. Neurogenetics. 2022; 23:45–58.

6. Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord. 2004; 19:630–640.

7. Hatate J, Miwa K, Matsumoto M, Sasaki T, Yagita Y, Sakaguchi M, et al. Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors. Parkinsonism Relat Disord. 2016; 26:29–34.

8. Veselý B, Antonini A, Rektor I. The contribution of white matter lesions to Parkinson’s disease motor and gait symptoms: a critical review of the literature. J Neural Transm (Vienna). 2016; 123:241–250.

9. Chen CH, Lee BC, Lin CH. Integrated plasma and neuroimaging biomarkers associated with motor and cognition severity in Parkinson’s disease. J Parkinsons Dis. 2020; 10:77–88.

10. Jouvent E, Duchesnay E, Hadj-Selem F, De Guio F, Mangin JF, Hervé D, et al. Prediction of 3-year clinical course in CADASIL. Neurology. 2016; 87:1787–1795.